S 
Sherwin-Williams SHW · USD
Materials · Chemicals · US listing · 🇺🇸 United States
S&P 500Dow Jones
357.93
+4.02%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$23.57bn
FY2016FY2025
Net income
$2.57bn
FY2016FY2025
Free cash flow
$2.65bn
FY2016FY2025
Shareholders' equity
$4.60bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.57bn | $23.10bn | $23.05bn | $22.15bn | $19.94bn | $18.36bn | $17.90bn | $17.53bn | $14.98bn | $11.86bn |
| Gross profit | $11.54bn | $11.20bn | $10.76bn | $9.33bn | $8.54bn | $8.68bn | $8.04bn | $7.42bn | $6.72bn | $5.92bn |
| Research and development | — | — | $196.6m | $119.3m | $115.9m | $97.1m | $103.1m | $51.9m | $58.5m | $58.0m |
| Operating income | $3.80bn | $3.76bn | $3.69bn | $3.00bn | $2.66bn | $2.85bn | $2.43bn | $1.89bn | $1.70bn | $1.71bn |
| Net income | $2.57bn | $2.68bn | $2.39bn | $2.02bn | $1.86bn | $2.03bn | $1.54bn | $1.11bn | $1.77bn | $1.13bn |
| Diluted earnings per share | 10.32 | 10.55 | 9.30 | 7.76 | 7.05 | 7.42 | 5.49 | 3.91 | 6.18 | 3.99 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $25.90bn | $23.63bn | $22.95bn | $22.59bn | $20.67bn | $20.40bn | $20.50bn | $19.13bn | $19.90bn | $6.75bn |
| Cash and short-term investments | $207.2m | $210.4m | $276.8m | $198.8m | $165.7m | $226.6m | $161.8m | $155.5m | $204.2m | $889.8m |
| Total liabilities | $21.30bn | $19.58bn | $19.24bn | $19.49bn | $18.23bn | $16.79bn | $16.37bn | $15.40bn | $16.25bn | $4.87bn |
| Debt | $10.87bn | $10.08bn | $9.85bn | $10.57bn | $9.62bn | $8.29bn | $8.69bn | $9.34bn | $10.52bn | $1.95bn |
| Shareholders' equity | $4.60bn | $4.05bn | $3.72bn | $3.10bn | $2.44bn | $3.61bn | $4.12bn | $3.73bn | $3.65bn | $1.88bn |
| Shares outstanding | 249m | 254m | 257m | 260m | 265m | 274m | 281m | 283m | 287m | 284m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $3.45bn | $3.15bn | $3.52bn | $1.92bn | $2.24bn | $3.41bn | $2.32bn | $1.94bn | $1.88bn | $1.31bn |
| Capital spending | −$797.6m | −$1.07bn | −$888.4m | −$644.5m | −$372.0m | −$303.8m | −$328.9m | −$251.0m | −$222.8m | −$239.0m |
| Free cash flow | $2.65bn | $2.08bn | $2.63bn | $1.28bn | $1.87bn | $3.10bn | $1.99bn | $1.69bn | $1.66bn | $1.07bn |
| Dividends paid | −$789.8m | −$723.4m | −$623.7m | −$618.5m | −$587.1m | −$488.0m | −$420.8m | −$322.9m | −$319.0m | −$312.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.79bn | $5.67bn | $5.60bn | $6.36bn | $6.31bn | $5.31bn | $5.30bn | $6.16bn |
| Gross profit | $3.34bn | $2.78bn | $2.73bn | $3.13bn | $3.12bn | $2.56bn | $2.57bn | $3.03bn |
| Operating income | $1.23bn | $810.9m | $778.7m | $1.17bn | $1.10bn | $754.3m | $673.5m | $1.13bn |
| Net income | $843.6m | $534.7m | $476.8m | $833.1m | $754.7m | $503.9m | $480.1m | $806.2m |
| Diluted earnings per share | 3.41 | 2.16 | 1.92 | 3.35 | 3.03 | 2.03 | 1.89 | 3.17 |
| Cash from operations | $1.35bn | $139.0m | $1.09bn | $1.31bn | $1.11bn | −$61.0m | $934.0m | $1.07bn |
| Capital spending | −$108.0m | −$138.0m | −$230.0m | −$196.0m | −$181.0m | −$189.0m | −$300.0m | −$235.0m |
| Free cash flow | $1.24bn | $1.0m | $862.0m | $1.11bn | $931.0m | −$250.0m | $634.0m | $839.0m |
| Total assets | $26.95bn | $26.38bn | $25.90bn | $26.21bn | $25.36bn | $24.64bn | $23.63bn | $23.97bn |
| Cash and short-term investments | $293.5m | $216.9m | $207.2m | $241.5m | $269.8m | $199.8m | $210.4m | $238.2m |
| Debt | $12.56bn | $12.18bn | $11.35bn | $12.00bn | $11.17bn | $11.25bn | $10.54bn | $10.60bn |
| Shareholders' equity | $3.85bn | $4.43bn | $4.60bn | $4.43bn | $4.40bn | $4.13bn | $4.05bn | $4.16bn |
Financial ratios
Data as of 10 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 48.9% | 48.5% | 46.7% | 42.1% | 42.8% | 47.3% | — | — |
| Operating margin | 16.1% | 16.3% | 16.0% | 13.5% | 13.4% | 15.5% | — | — |
| Net margin | 10.9% | 11.6% | 10.4% | 9.1% | 9.3% | 11.1% | — | — |
| Return on equity | 55.9% | 66.2% | 64.3% | 65.1% | 76.5% | 56.2% | — | — |
| Return on assets | 9.9% | 11.3% | 10.4% | 8.9% | 9.0% | 10.0% | — | — |
| Free cash flow yield | 5.3% | 5.2% | 5.4% | 3.1% | 3.1% | 4.2% | — | — |
| Revenue growth | 2.1% | 0.2% | 4.1% | 11.1% | 8.6% | 2.6% | — | — |
| Earnings growth | -4.2% | 12.2% | 18.3% | 8.4% | -8.2% | 31.7% | — | — |
| Current ratio | 0.87x | 0.79x | 0.83x | 0.99x | 0.88x | 1.00x | — | — |
| Debt to equity | 2.47x | 2.56x | 2.77x | 3.54x | 4.11x | 2.40x | — | — |
| Equity ratio | 17.8% | 17.1% | 16.2% | 13.7% | 11.8% | 17.7% | — | — |
| Interest coverage | 8.11x | 8.72x | 8.84x | 7.45x | 7.72x | 8.14x | — | — |
| R&D as a share of sales | — | — | 0.9% | 0.5% | 0.6% | 0.5% | 0.6% | 0.3% |
| Buybacks as a share of market value | 2.1% | 1.1% | 1.3% | 1.6% | 3.4% | 2.5% | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.1% | 5.1% | 7.6% |
| Operating income | 8.2% | 5.9% | 8.9% |
| Net income | 8.3% | 4.8% | 9.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 48.7% | 46.6% | 46.1% | 46.0% |
| Operating margin | 16.2% | 15.5% | 15.2% | 14.3% |
| Net margin | 11.2% | 10.5% | 10.4% | 9.9% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 31.4 | 32.2 | 33.5 | 30.6 | 50.0 | 33.6 | 36.0 | 34.0 | 22.5 | 22.8 |
| Price to sales | 3.4 | 3.7 | 3.5 | 2.8 | 4.7 | 3.7 | 3.1 | 2.1 | 2.7 | 2.2 |
Market value over time
31 Oct 2016 to 9 Sept 2026, in USD
$23.18bn$79.23bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -7% | 13% | 29% | -29% | 36% | 26% | 53% | -8% | 56% | 4% |
Dividends and splits
Per share, in the currency the company pays
Paid for 46 years. Last went ex-dividend on 21 Aug 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 2.40 | 3.16 | 2.86 | 2.42 | 2.40 | 2.20 | 1.787 | 1.507 |
- 3-for-1 split · 1 Apr 2021
- 2-for-1 split · 31 Mar 1997
- 2-for-1 split · 1 Apr 1991
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.